anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
<P>PROBLEM TO BE SOLVED: To provide an inexpensive agent for preventing and/or treating infectious diseases of fish-and-shellfish without any side effects, to provide a method for preventing and/or treating such infectious diseases by administering fish-and-shellfish with the above agent, to provide feed containing the above agent, to provide a method for cultivating fish-and-shellfish by giving the feed thereto, and to provide a method for producing a sulfated fucoidan, thus ameliorating such infectious diseases of fish-and-shellfish in its culture site.  <P>SOLUTION: The agent for preventing and/or treating infectious diseases of fish-and-shellfish comprises sulfated fucoidan as an active ingredient. The method for preventing and/or treating such infectious diseases comprises administering fish-and-shellfish with the above agent. The feed for cultivating fish-and-shellfish contains the above agent. The method for cultivating fish-and-shellfish comprises giving the feed thereto. The method for producing the sulfated fucoidan is also provided, involving the step of conducting a fucoidan sulfation treatment by mixing fucoidan with a sulfurized amine-based compound under an acidic condition.  <P>COPYRIGHT: (C)2008,JPO&INPIT
Carcinogenesis and fertility studies have not been performed. Atracurium was evaluated in a battery of three short-term mutagenicity tests. It was non-mutagenic in both the Ames Salmonella assay at concentrations up to 1000 mcg/plate, and in a rat bone marrow cytogenicity assay at up to paralyzing doses. A positive response was observed in the mouse lymphoma assay under conditions (80 and 100 mcg/mL, in the absence of metabolic activation) which killed over 80% of the treated cells; there was no mutagenicity at 60 mcg/mL and lower, concentrations which killed up to half of the treated cells. A far weaker response was observed in the presence of metabolic activation at concentrations (1200 mcg/mL and higher) which also killed over 80% of the treated cells. 

Mutagenicity testing is intended to simulate chronic (years to lifetime) exposure in an effort to determine potential carcinogenicity. Thus, a single positive mutagenicity response for a drug used infrequently and/or briefly is of questionable clinical relevance.
Ticagrelor is an oral, reversibly-binding, direct-acting P2Y12 receptor antagonist used clinically for the prevention of atherothrombotic events in patients with acute coronary syndromes (ACS). Guideline recommendations on the use of dual antiplatelet therapy have been formulated that ticagrelor 90 mg twice daily plus aspirin in preference to clopidogrel 75mg daily plus aspirin for ACS patients. However, few East Asian patients have been included in these trials to assess the use of these drugs. In addition, a growing body of data supported that East Asian might have different adverse event profiles (thrombophilia and bleeding) and "therapeutic window" compared with white subjects. In Korea and Japan, it has been recently reported that low doses of ticagrelor might have a more potent inhibition of platelet aggregation than clopidogrel (75 mg once daily) in healthy subjects and patients with stable coronary artery disease, respectively. But it is still not clear whether a low dose of ticagrelor is superior to clopidogrel in diabetic patients with stable coronary disease. A recent study on pharmacokinetics and tolerability of ticagrelor has found that maximum plasma concentration and area under the plasma concentration-time curve of ticagrelor (90 mg twice daily) and its active metabolite (AR-C124910XX) tended to be approximately 40% higher in healthy Chinese volunteers compared with Caucasian subjects. This data also suggested that a low dose of ticagrelor might be more appropriate for Chinese patients with coronary heart disease. In view of a large diurnal variation with a single daily dose, a lower dose twice daily may be a better choice for Chinese patients.

Recent studies found that antiplatelet drugs might have anti-inflammatory effects and protect endothelial function. ACS patients treated by ticagrelor had a significantly higher increase in levels of circulating progenitor cells compared to those treated by clopidogrel, suggesting a benefit on endothelial regeneration that may participate in the pleiotropic property of the drug. This may prompt the regression of blood vessels and the endothelium stability. But it is not very clear that the effect of low-dose ticagrelor on vascular endothelial function in diabetic patients with stable coronary artery disease.

Therefore, the investigators performed this randomized, single-blind clinical trial to observe the effects of different doses of ticagrelor and standard-dose clopidogrel on platelet aggregation and endothelial function in diabetic patients with stable coronary artery disease.
OBJECTIVES: Vesicovaginal fistulas (VVF) are the most commonly acquired fistulas of the urinary tract. The management of VVF is mainly based on expert opinion and surgeon experience. This study aims to provide the practice patterns and outcomes of vesicovaginal fistula (VVF) management in Indonesia.
METHODS: This study utilizes the results of a survey among the surgeons who performs VVF repair in referral hospitals throughout Indonesia between June and July of 2021. Data analysis was carried out with SPSS descriptively by displaying the relative frequency of the answers to each question of the questionnaire form.
RESULTS: We collected responses from 93 respondents consisting of 68 urologists and 25 gynecologists. The most commonly reported cause of VVF was obstetric (50.5%). Most respondents confirmed the diagnosis of VVF by cystoscopy (81.7%). Waiting time to repair VVF was generally 12 weeks (79.6%), while the transvaginal approach repair was more often performed (77.4%). An additional procedure, such as tissue interposition was performed in 50.5% of cases. Tissue interposition was mostly indicated in recurrent VVF (81%), with omentum being the most selected tissue interposition (71%). When indicated, the most selected method of transabdominal approach was open transvesical (54,84%). A laparoscopic approach was performed only in 7.5% of cases. Overall, the success rate for VVF repair in Indonesia was 70-100% at first attempt.
CONCLUSIONS: The transvaginal approach is preferred, either with or without an interposition tissue flap. The success rate at the first attempt is satisfactory.
Butylparaben, a common preservative, is widely used in food, pharmaceuticals and personal care products. Epidemiological studies have revealed the close relationship between butylparaben and diabetes; however the mechanisms of action remain unclear. In this study, we administered butylparaben orally to mice and observed that exposure to butylparaben induced glucose intolerance and hyperlipidemia. RNA sequencing results demonstrated that the enrichment of differentially expressed genes was associated with lipid metabolism, bile acid metabolism, and inflammatory response. Western blot results further validated that butylparaben promoted hepatic lipogenesis, inflammation, gluconeogenesis, and insulin resistance through the inhibition of the farnesoid X receptor (FXR) pathway. The FXR agonists alleviated the butylparaben-induced metabolic disorders. Moreover, 16 S rRNA sequencing showed that butylparaben reduced the abundance of Bacteroidetes, S24-7, Lactobacillus, and Streptococcus, and elevated the Firmicutes/Bacteroidetes ratio. The gut microbiota dysbiosis caused by butylparaben led to decreased bile acids (BAs) production and increased inflammatory response, which further induced hepatic glycolipid metabolic disorders. Our results also demonstrated that probiotics attenuated butylparaben-induced disturbances of the gut microbiota and hepatic metabolism. Taken collectively, the findings reveal that butylparaben induced gut microbiota dysbiosis and decreased BAs production, which further inhibited FXR signaling, ultimately contributing to glycolipid metabolic disorders in the liver.
This study present a case of a 49-year-old woman who suffered from resistant hypertension, hypokalemia, hypomenorrhea, and infertility. She was hospitalized 6 years earlier for hypomenorrhea and abdominal pain at the Xiamen Maternity and Child Health Hospital, where she was diagnosed with Asherman syndrome. During hospitalization, a computed tomography examination revealed an adrenal mass. She was referred to Xiamen University Affiliated Zhongshan Hospital for pheochromocytoma and underwent surgical resection of the left adrenal gland. The adrenal cortex adenoma was confirmed by pathological biopsy. Six years later, the patient also presented with hypertension and hypokalemia to our emergency department. A diagnosis of 17α-hydroxylase deficiency was established through the analysis of clinical and laboratory characteristics. The genetic analysis of CYP17A1 revealed compound heterozygous mutations, 1 of which was a mutation of c.1226 C>G, and the other c.297+2T>C.
A lyophilized bendamustine composition consisting of bendamustine hydrochloride, an aqueous solvent, and optionally an excipient, and a method of preparation thereof for treating a condition in a subject are provided. The aqueous solvent includes, for example, water, an acid, a base, or a salt, etc. The excipient includes at least one cryoprotectant, for example, sucrose, trehalose, mannitol, etc. A pre-lyophilization bendamustine composition is lyophilized, for example, by freezing, primary drying, annealing, secondary drying, condensed cooling and evacuation at preset temperatures to obtain the lyophilized bendamustine composition as a cake, a powder, or a solid concentrate. The lyophilized bendamustine composition is free of a non-aqueous solvent. Reconstitution is performed by mixing the lyophilized bendamustine composition with an aqueous solvent for about 30 seconds to 300 seconds. The reconstituted bendamustine product containing about 0.2 wt % to about 2.5 wt % by weight of impurities is administered to the subject in need thereof.
All products were used according to the manufacturer's instructions. KP24 and Banlice were applied twice separated by a one week interval. MOOV Head Lice Treatment was applied on Day 0, Day 7 and Day 14. The cure rate (absence of live lice) one day after the first administration for all products was a secondary outcome measure. The cure rate at 7 days after the final administration (Day 14 for Banlice or KP24 and at Day 21 for MOOV Head Lice Treatment) was the primary outcome measure. Siblings were treated if these were found to be infected as an enrolment criteria.
The work-related musculoskeletal disorders (MSDs) have substantially increased worldwide from the 1980s In Brazil, MSDs are the leading cause of occupational diseases. The harm to society is enormous and justifies the study of methods to prevent them and / or reduce them. Many authors have evaluated isolated approaches to manage the problem, but as this is usually multifactorial, a set of interventions could bring better results. Physiotherapy is a specialty that works to improve working conditions through ergonomic interventions, physical therapy treatments and gymnastics and thus contributes to prevention and treatment of these disorders. The objective of this study is: to determine the effect of this set of interventions on the quality of life of workers and the productivity of a company that has been evaluated in a previous study to this. The study population will consist of 185 employees of a multinational company that manufactures and sells hearing aids in Brazil. Of those, 126 made up the experimental group (headquarter) and 59 control group (subsidiaries). Two questionnaires, one on musculoskeletal symptoms and another on risk factors at work are applied. An ergonomic evaluation of activities and tasks will be held, which will assist the diagnosis of situations which may be modified by ergonomic measures. Management of pre-existing complaints by acupuncture and orientation of specific exercises are used. The program's effectiveness analysis will be done by two methods: a questionnaire assessing the perception of workers about the their quality of life at work and the number of musculoskeletal complaints pre and post-intervention.
<P>PROBLEM TO BE SOLVED: To provide a new compound useful for the inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies.  <P>SOLUTION: The present invention relates to a new compound useful for the inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to a pharmaceutical formulation containing these compounds and methods of using the compounds for the inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of the invention can be used as therapeutic or prophylactic agents. The agents are particularly well-suited for the treatment of many inflammatory and autoimmune diseases.  <P>COPYRIGHT: (C)2008,JPO&INPIT
BACKGROUND: Midfoot arthrodesis is a common procedure performed both for arthritis and correction of deformity. The optimal fixation for midfoot arthrodesis has not been established, though numerous studies have been investigating the fixation techniques of midfoot arthrodesis. The purpose of this study was to compare the union rate of midfoot arthrodesis using 4 different fixation strategies and investigate risk factors of nonunion following midfoot arthrodesis.
METHODS: A retrospective chart review was performed for patients who underwent midfoot joint arthrodesis between January 2014 and May 2019. The rates of nonunion and postoperative complication were compared among 4 different fixation constructs: staple fixation, compression plate fixation, compression plate with lag screw fixation, and compression screw fixation. Predictors of nonunion following midfoot arthrodesis were investigated through a multivariable logistic regression analysis. A total of 95 patients (99 feet), including 240 midfoot joints were included in this study. The mean follow-up period was 78.4 weeks.
RESULTS: Overall, bony union was achieved in 86 out of 99 (86.9%) patients, which included 218 out of 240 (90.8%) midfoot joints. A significant difference in the nonunion rate according to the type of fixation construct was found (P = .011); the compression screw alone fixation construct was noted to have a significantly higher nonunion rate than other fixation constructs. Diabetes mellitus (odds ratio [OR] = 0.179 [95% CI: 0.059, 0.542]), the type of fixation construct (compression screw alone; OR =1.789 [95% CI: 1.071, 2.978]), lack of adjuvant bone graft (OR = 2.803 [95% CI: 1.081, 7.268], and postoperative nonanatomical alignment (OR = 3.937 [95% CI: 1.278, 12.126]) were identified as independent predictors of nonunion following midfoot arthrodesis.
CONCLUSION: The rate of nonunion following midfoot arthrodesis among 4 different commonly used fixation constructs was compared in this study. Risk factors of nonunion were investigated revealing that diabetes mellitus, compression screw fixation alone, lack of adjuvant bone graft, and postoperative nonanatomical alignment are independent predictors of nonunion following midfoot arthrodesis.
LEVELS OF EVIDENCE: Level III: Comparative cohort study.
PURPOSE:To provide the cosmetic material which is enhanced in safety, is washable with water and has the use feel similar to that of cosmetic materials for human beings by incorporating at least 5 to 80wt.% polyethylene glycol having >=1000 average mol.wt. and 20 to 70wt.% pigments into this material. CONSTITUTION:Any pigments are usable, insofar as the pigments are nontoxic. The pigments are incorporated into a liquid compsn. at 20 to 70wt.% thereof and the polyethylene glycol has >=1000 average mol.wt. and is incorporated at 5 to 80wt.% therein. The application to most of the resins used for dolls is possible in this way. Since the pigments can be dispersedly held, the dyeing of the dolls does not arise and the color fading by light beams does not arise either. The polyethylene glycol is pasty solid, maintains the appearance and characteristic of the cosmetic material and dissolves in water and can, therefore, be washed away with water. The playgame mind of children is satisfied by the appearance similar to that of the cosmetic materials used for human beings. The cosmetic material compounded with 5 to 30wt.% surfactant of >=8HLB is enhanced in washability with water.
BACKGROUND: Electroconvulsive therapy (ECT) is highly efficacious in catatonia yet remains underutilized in pediatric patients. Practice guidelines recommend bilateral placement in cases with urgent need for response such as catatonia. Because of significantly lower cognitive burden and efficacy (compared to bilateral), right unilateral placement (RUL) is preferred for major depression. Increasing literature shows RUL is effective for catatonia in adults, but its use in catatonic youth is largely unknown.
OBJECTIVES: The aims of the study are to describe naturalistic outcomes of ECT in pediatric patients with catatonia and to discuss ECT parameter considerations.
METHODS: This is a retrospective chart review of patients under 18-years of age at Saint Louis Children's Hospital with diagnosis of catatonia who received ECT from 2019 to November 2023. All cases received ECT per clinical protocol. Catatonic symptoms were monitored using the Busch Francis Catatonia Scale. Institutional review board approved the study.
RESULTS: Twelve inpatients with debilitating catatonia and a failed benzodiazepine trial underwent ECT. Ten of these 12 patients initiated RUL placement, one received bifrontal, and another bilateral. All patients achieved resolution of catatonia: 6 patients with RUL alone and 4 who started with RUL later switched to bilateral due to nonresponse. The patient receiving bifrontal switched to bilateral due to nonresponse. Patients with malignant catatonia preferentially responded to bilateral placement. Patients experienced expected side effects from ECT.
CONCLUSIONS: RUL ECT was effective for catatonia in pediatric patients and can be considered as initial placement. A switch to bilateral can be considered in nonresponse, similar to current approach for major depression. For malignant catatonia, bilateral placement remains preferential.
The invention relates to the technical field of treatment and prevention of injury pain diseases and chronic diseases, in particular to a blood-activating and collateral-dredging traditional Chinese medicine composition and a preparation method thereof. Notopterygium root, pubescent angelica root, prepared wild aconite root, prepared Sichuan aconite root, large-leaf gentian root, myrrh, frankincense, cyperus tuber, prepared arisaema tuber, raw pangolin scales and cowherb seed are used as ministerial medicines for promoting blood circulation and reducing swelling. Achyranthes and cyathula root, earthworm, root of Dahurian angelica, root of common peony and ground beetle, root of common peony and root of Dahurian angelica, root of herbaceous peony, etc. are added or subtracted according to the different symptoms. In the preparation process of the paste, the medicinal materials are extracted after being crushed and then mixed with the auxiliary materials, so that the weakening of the drug effect of the extracted traditional Chinese medicine is reduced. The prepared ointment is not greasy, is easy to be absorbed by the skin of a human body, and can reach the texture to achieve effective treatment.
Participants were expected to attend 4 office visits. Visit 1 was the Screening/Enrollment visit. At Visit 2 (Baseline Visit), participants were randomized and the study lenses were trial fit. At Visit 3 (Dispense Visit), participants received study lenses for approximately 1 week of wear. Visit 4 was the Exit visit. Expected duration of participation in the study was 3 weeks.
PURPOSE:To obtain a dentifrice composition having excellent antiinflammatory effects to prevent inflammation of the gum of periodontitis, etc., comprising an extract containing hederagenin extracted from the pericarp of Sapindus mukurossi Gaertn. and/or whole grass of Akebia quinata Decne. as an essential component. CONSTITUTION:A dentifrice composition comprising an extract containing hederagenin shown by the formula having excellent antiplasmin activity, antikallikrein activity and antitrypsin activity as an essential component. The extract is obtained by using the pericarp of Sapindus mukurossi Gaertn. and/or whole grass of Akebia quinata Decne. in a raw state, a dried material or a dried and powdered material thereof and by extracting the pericarp of Sapindus mukurossi Gaertn. and/or whole grass of Akebia quinata Decne. etc., with a hydrous alcohol or water as a solvent under heating and filtering the extracted solution. The filtrate is concentrated under reduced pressure to give an ointment essence or the essence is dried further to give dried powder. The ointment essence or the dried power is blended as a component of dentifrice.
The present invention discloses novel chemical compounds obtained by causing a covalent attachment of a modifying agent of the structure provided for formula 1, to a functional group or a heteroatom of a heterocyclic ring system in chemical compound with improved chemical and biological properties; Wherein : Y is DRUG-CO; DRUG -OCO; DRUG-NRCO, and X is selected from. With a provisio that the modification can be done at more than one functional group in the DRUG. Alternatively : Y is DRUG-CR1 R2, and X is COR, CONRR2, COOR. With a provisio that the N of the drug is attached to CR1 R2. With a provisio that the modification can be done at more than one functional group in the DRUG. G can be selected from iodide, chloride, bromide, mesylate, tosylate or tetra flouroborate or any other pharmaceutically acceptable anion. G can be either one or more counter ions to balance the charge. R, R1 and R2 are independently H, C1-C8 straight or branched chain alkyl - optionally containing 1 -3 heteroatoms selected from O, N, S, SO, or SO2; 3-7 membered cycloalkyl optionally containing 1 -3 heteroatoms selected from O, N, S, SO, or SO2 and or lower alkyl, straight or branched alkyl, alkoxy; alkaryl, aryl, heteroaryl, or alkheteroaryl; or is independently is independently part of 3-7 membered ring optionally containing additional 1 -2 heteroatoms selected from, O, N, S, SO, SO2 and also be optionally substituted with alkoxy, F or CI. The present invention also discloses a method for obtaining these compounds.
A computer-implemented method for automated diagnosis of cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM) performed by an automated workflow engine executed by at least one processor includes separating a plurality of echocardiogram (echo) images a heart according to 2D images and Doppler modality images. The 2D images are classified by view type, including A4C video. The 2D images are segmented to produce segmented A4C images having a segmentation mask over the left ventricle. Phase detection is performed on the segmented A4C images to determine systole and diastole endpoints per cardiac cycle. Disease classification is performed on beat-to-beat A4C images for respective cardiac cycles. The cardiac cycle probability scores generated for all of the cardiac cycles are aggregated for each A4C video, and the aggregated probability scores for all the A4C videos are combined to generate a patient-level conclusion for CA and HCM.
A method and system for analysing data displayed by ventilators is disclosed. The method includes receiving one or more images of a display screen associated with a ventilator. The display screen is configured to display data representation corresponding to one or more health parameters obtained by the ventilator for a patient. The method further includes processing the one or more image, using at least one machine learning algorithm, to extract the data representation. The method includes generating numerical data corresponding to the one or more health parameters, based on the data representation. The method further includes retrieving the one or more health parameters associated with the patient using the numerical data.